Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Hippocampal microstructural architecture and surgical outcome: Hippocampal diffusivity could predict seizure relapse.

Sala-Padro J, Miró J, Rodriguez-Fornells A, Quintana M, Vidal N, Plans G, Santurino M, Falip M, Camara E.

Seizure. 2020 Jan 26;76:84-88. doi: 10.1016/j.seizure.2020.01.006. [Epub ahead of print]

PMID:
32044692
2.

Usefulness of HMPAO-SPECT in the diagnosis of nonconvulsive status epilepticus.

Jaraba S, Reynés-Llompart G, Sala-Padró J, Veciana M, Miró J, Pedro J, Puig O, Mora J, Falip M.

Epilepsy Behav. 2019 Dec;101(Pt B):106544. doi: 10.1016/j.yebeh.2019.106544. Epub 2019 Nov 18.

PMID:
31753769
3.

Use of intravenous brivaracetam in status epilepticus: A multicenter registry.

Santamarina E, Parejo Carbonell B, Sala J, Gutiérrez-Viedma Á, Miró J, Asensio M, Abraira L, Falip M, Ojeda J, López-González FJ, Rodríguez-Osorio X, Mauri JÁ, Aiguabella M, García Morales I, Toledo M.

Epilepsia. 2019 Aug;60(8):1593-1601. doi: 10.1111/epi.16094. Epub 2019 Jul 1.

PMID:
31260101
4.

Autobiographical memory in epileptic patients after temporal lobe resection or bitemporal hippocampal sclerosis.

Miró J, Ripollés P, Sierpowska J, Santurino M, Juncadella M, Falip M, Rodríguez-Fornells A.

Brain Imaging Behav. 2019 May 17. doi: 10.1007/s11682-019-00113-8. [Epub ahead of print]

PMID:
31102166
5.

Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies.

Falip M, Rodriguez-Bel L, Castañer S, Sala-Padró J, Miro J, Jaraba S, Casasnovas C, Morandeira F, Berdejo J, Carreño M.

Front Neurol. 2019 Jan 9;9:1143. doi: 10.3389/fneur.2018.01143. eCollection 2018.

6.

Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.

Villanueva V, Montoya J, Castillo A, Mauri-Llerda JÁ, Giner P, López-González FJ, Piera A, Villanueva-Hernández P, Bertol V, Garcia-Escrivá A, Garcia-Peñas JJ, Garamendi I, Esteve-Belloch P, Baiges-Octavio JJ, Miró J, Falip M, Garcés M, Gómez A, Gil-López FJ, Carreño M, Rodriguez-Uranga JJ, Campos D, Bonet M, Querol R, Molins A, Tortosa D, Salas-Puig J.

Epilepsia. 2018 Sep;59(9):1740-1752. doi: 10.1111/epi.14522. Epub 2018 Jul 31.

7.

Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.

Gil-López FJ, Montoya J, Falip M, Aparicio J, López-González FJ, Toledano R, Gil-Nagel A, Molins A, García I, Serrano P, Domenech G, Torres F, Donaire A, Carreño M.

Acta Neurol Scand. 2018 Aug;138(2):122-129. doi: 10.1111/ane.12931. Epub 2018 Mar 24.

PMID:
29573400
8.

Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.

Striano P, McMurray R, Santamarina E, Falip M.

Epileptic Disord. 2018 Feb 1;20(1):13-29. doi: 10.1684/epd.2017.0950. Review.

9.

Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations.

Cross JH, Auvin S, Falip M, Striano P, Arzimanoglou A.

Front Neurol. 2017 Sep 29;8:505. doi: 10.3389/fneur.2017.00505. eCollection 2017. Review.

10.

Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.

Falip M, Rodriguez-Bel L, Castañer S, Miro J, Jaraba S, Mora J, Bas J, Carreño M.

Acta Neurol Scand. 2018 Feb;137(2):272-276. doi: 10.1111/ane.12799. Epub 2017 Aug 2.

PMID:
28766694
11.

Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.

Toledano R, Jovel CE, Jiménez-Huete A, Bayarri PG, Campos D, Gomariz EL, Giráldez BG, García-Morales I, Falip M, Agredano PM, Palao S, Prior MJAA, Pascual MRQ, Navacerrada FJ, González FJL, Ojeda J, Sáez AA, Bermejo PE, Gil-Nagel A.

Epilepsy Behav. 2017 Aug;73:173-179. doi: 10.1016/j.yebeh.2017.02.028. Epub 2017 Jun 20.

PMID:
28641170
12.

Unraveling the Role of the Hippocampus in Reversal Learning.

Vilà-Balló A, Mas-Herrero E, Ripollés P, Simó M, Miró J, Cucurell D, López-Barroso D, Juncadella M, Marco-Pallarés J, Falip M, Rodríguez-Fornells A.

J Neurosci. 2017 Jul 12;37(28):6686-6697. doi: 10.1523/JNEUROSCI.3212-16.2017. Epub 2017 Jun 7.

13.

Auditory Target and Novelty Processing in Patients with Unilateral Hippocampal Sclerosis: A Current-Source Density Study.

Vilà-Balló A, François C, Cucurell D, Miró J, Falip M, Juncadella M, Rodríguez-Fornells A.

Sci Rep. 2017 May 9;7(1):1612. doi: 10.1038/s41598-017-01531-8.

14.

Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies.

Carreño M, Bien CG, Asadi-Pooya AA, Sperling M, Marusic P, Elisak M, Pimentel J, Wehner T, Mohanraj R, Uranga J, Gómez-Ibáñez A, Villanueva V, Gil F, Donaire A, Bargalló N, Rumià J, Roldán P, Setoain X, Pintor L, Boget T, Bailles E, Falip M, Aparicio J, Dalmau J, Graus F.

Epilepsy Res. 2017 Jan;129:101-105. doi: 10.1016/j.eplepsyres.2016.12.010. Epub 2016 Dec 15.

15.

Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures.

Toledo M, Gonzalez-Cuevas M, Miró-Lladó J, Molins-Albanell A, Falip M, Martinez AB, Fernandez S, Quintana M, Cambrodi R, Santamarina E, Salas-Puig J.

Epilepsy Behav. 2016 Oct;63:57-62. doi: 10.1016/j.yebeh.2016.08.004. Epub 2016 Aug 24.

PMID:
27566967
16.

Rufinamide in children and adults in routine clinical practice.

Jaraba S, Santamarina E, Miró J, Toledo M, Molins A, Burcet J, Becerra JL, Raspall M, Pico G, Miravet E, Cano A, Fossas P, Fernández S, Falip M.

Acta Neurol Scand. 2017 Jan;135(1):122-128. doi: 10.1111/ane.12572. Epub 2016 Feb 29.

PMID:
26923380
17.

Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?

Miro J, Jaraba S, Juvany R, Santurino M, Cobo S, Falip M.

Clin Neuropharmacol. 2016 May-Jun;39(3):121-4. doi: 10.1097/WNF.0000000000000138.

PMID:
26818046
18.

Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome.

Falip M, Miró J, Jaraba S, Cusó S, Capdevila O, Graus F, Martínez-Yélamos A.

Scand J Rheumatol. 2015;44(6):515-7. doi: 10.3109/03009742.2015.1041155. Epub 2015 Jul 13. No abstract available.

PMID:
26165723
19.

Refractory status epilepticus due to SMART syndrome.

Jaraba S, Puig O, Miró J, Velasco R, Castañer S, Rodríguez L, Izquierdo C, Simó M, Veciana M, Falip M.

Epilepsy Behav. 2015 Aug;49:189-92. doi: 10.1016/j.yebeh.2015.05.033. Epub 2015 Jun 11.

PMID:
26071996
20.

EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis.

Veciana M, Becerra JL, Fossas P, Muriana D, Sansa G, Santamarina E, Gaig C, Carreño M, Molins A, Escofet C, Ley M, Vivanco R, Pedro J, Miró J, Falip M; Epilepsy Group of the SCN.

Epilepsy Behav. 2015 Aug;49:280-5. doi: 10.1016/j.yebeh.2015.04.032. Epub 2015 Jun 10.

PMID:
26071995
21.

Vagus nerve stimulation therapy is effective and safe for startle-induced seizures.

Miró J, Jaraba S, Mora J, Puig O, Castañer S, Rodriguez-Bel L, Santurino M, Plans G, Falip M.

J Neurol Sci. 2015 Jul 15;354(1-2):124-6. doi: 10.1016/j.jns.2015.04.048. Epub 2015 May 7. No abstract available.

PMID:
25979636
22.

Interhemispheric microstructural connectivity in bitemporal lobe epilepsy with hippocampal sclerosis.

Miró J, Gurtubay-Antolin A, Ripollés P, Sierpowska J, Juncadella M, Fuentemilla L, Sánchez V, Falip M, Rodríguez-Fornells A.

Cortex. 2015 Jun;67:106-21. doi: 10.1016/j.cortex.2015.03.018. Epub 2015 Apr 1.

PMID:
25955498
23.

Hypoglycemic seizures and epilepsy in type I diabetes mellitus.

Falip M, Miró J, Carreño M, Jaraba S, Becerra JL, Cayuela N, Perez Maraver M, Graus F.

J Neurol Sci. 2014 Nov 15;346(1-2):307-9. doi: 10.1016/j.jns.2014.08.024. Epub 2014 Aug 27.

PMID:
25183236
24.

Human Hippocampus Arbitrates Approach-Avoidance Conflict.

Bach DR, Guitart-Masip M, Packard PA, Miró J, Falip M, Fuentemilla L, Dolan RJ.

Curr Biol. 2014 Jun 16;24(12):1435. doi: 10.1016/j.cub.2014.05.051. Epub 2014 Jun 16. No abstract available.

25.

Atypical language organization in temporal lobe epilepsy revealed by a passive semantic paradigm.

Miró J, Ripollés P, López-Barroso D, Vilà-Balló A, Juncadella M, de Diego-Balaguer R, Marco-Pallares J, Rodríguez-Fornells A, Falip M.

BMC Neurol. 2014 May 6;14:98. doi: 10.1186/1471-2377-14-98.

26.

Antithyroid antibodies as a potential marker of autoimmune-mediated late onset temporal lobe epilepsy.

Miró J, Fortuny R, Juncadella M, Aiguabella M, Veciana M, Castañer S, Santurino M, Falip M.

Clin Neurol Neurosurg. 2014 Jun;121:46-50. doi: 10.1016/j.clineuro.2014.03.017. Epub 2014 Mar 25.

PMID:
24793474
27.

Human hippocampus arbitrates approach-avoidance conflict.

Bach DR, Guitart-Masip M, Packard PA, Miró J, Falip M, Fuentemilla L, Dolan RJ.

Curr Biol. 2014 Mar 3;24(5):541-7. doi: 10.1016/j.cub.2014.01.046. Epub 2014 Feb 20. Erratum in: Curr Biol. 2014 Jun 16;24(12):1435.

28.

Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.

Miró J, Aiguabella M, Veciana M, Juvany R, Santurino M, Leiva E, Salas-Puig J, Falip M.

Acta Neurol Scand. 2014 May;129(5):e20-3. doi: 10.1111/ane.12216. Epub 2013 Dec 24.

PMID:
24372179
29.

Combination of corpus callosotomy and vagus nerve stimulation in the treatment of refractory epilepsy.

Guillamón E, Miró J, Gutiérrez A, Conde R, Falip M, Jaraba S, Plans G, Garcés M, Villanueva V.

Eur Neurol. 2014;71(1-2):65-74. doi: 10.1159/000353979. Epub 2013 Dec 5.

PMID:
24334999
30.

Hippocampus-dependent strengthening of targeted memories via reactivation during sleep in humans.

Fuentemilla L, Miró J, Ripollés P, Vilà-Balló A, Juncadella M, Castañer S, Salord N, Monasterio C, Falip M, Rodríguez-Fornells A.

Curr Biol. 2013 Sep 23;23(18):1769-75. doi: 10.1016/j.cub.2013.07.006. Epub 2013 Sep 5.

31.

Causes of CNS inflammation and potential targets for anticonvulsants.

Falip M, Salas-Puig X, Cara C.

CNS Drugs. 2013 Aug;27(8):611-23. doi: 10.1007/s40263-013-0078-6. Review.

PMID:
23771734
32.

Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.

Miró J, Toledo M, Santamarina E, Ricciardi AC, Villanueva V, Pato A, Ruiz J, Juvany R, Falip M.

Seizure. 2013 Jan;22(1):77-9. doi: 10.1016/j.seizure.2012.10.004. Epub 2012 Nov 3.

33.

Surgical versus conservative treatment in patients with cerebral cavernomas and non refractory epilepsy.

Fernández S, Miró J, Falip M, Coello A, Plans G, Castañer S, Acebes JJ.

Seizure. 2012 Dec;21(10):785-8. doi: 10.1016/j.seizure.2012.09.004. Epub 2012 Sep 23.

34.

Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study.

Sierra-Marcos A, Maestro I, Rodríguez-Osorio X, Miró J, Donaire A, Aparicio J, Rumiá J, Forcadas M, Garamendi I, Pardo J, López J, Prieto Á, Plans G, Falip M, Carreño M.

Eur J Neurol. 2012 Sep;19(9):1219-23. doi: 10.1111/j.1468-1331.2012.03707.x. Epub 2012 Mar 26.

PMID:
22891774
35.

Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.

Falip M, Carreño M, Miró J, Saiz A, Villanueva V, Quílez A, Molins A, Barceló I, Sierra A, Graus F.

Eur J Neurol. 2012 Jun;19(6):827-33. doi: 10.1111/j.1468-1331.2011.03609.x. Epub 2012 Feb 21.

PMID:
22353320
36.

Analysis of automated methods for spatial normalization of lesioned brains.

Ripollés P, Marco-Pallarés J, de Diego-Balaguer R, Miró J, Falip M, Juncadella M, Rubio F, Rodriguez-Fornells A.

Neuroimage. 2012 Apr 2;60(2):1296-306. doi: 10.1016/j.neuroimage.2012.01.094. Epub 2012 Jan 28.

PMID:
22305954
37.

Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.

García-Morales I, Delgado RT, Falip M, Campos D, García ME, Gil-Nagel A.

Seizure. 2011 Dec;20(10):801-4. doi: 10.1016/j.seizure.2011.08.005. Epub 2011 Sep 13.

38.

Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study.

Aiguabella M, Falip M, Villanueva V, de la Peña P, Molins A, Garcia-Morales I, Saiz RA, Pardo J, Tortosa D, Sansa G, Miró J.

Seizure. 2011 Jan;20(1):60-4. doi: 10.1016/j.seizure.2010.10.009. Epub 2010 Dec 10.

39.

Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease.

Aiguabella M, Falip M, Veciana M, Bruna J, Palasí A, Corral L, Herrero JI, Boluda S, Mora J, Iranzo A, Serrano C.

Epileptic Disord. 2010 Sep;12(3):239-42. doi: 10.1684/epd.2010.0318. Epub 2010 Jul 19.

40.

Sequential analysis of fMRI images: A new approach to study human epileptic networks.

Donaire A, Falcón C, Carreno M, Bargallo N, Rumià J, Setoain J, Maestro I, Boget T, Pintor L, Agudo R, Falip M, Fernández S.

Epilepsia. 2009 Dec;50(12):2526-37. doi: 10.1111/j.1528-1167.2009.02152.x. Epub 2009 Jun 1.

41.

Validation of the Spanish version of the Liverpool Adverse Events Profile in patients with epilepsy.

Carreño M, Donaire A, Falip M, Maestro I, Fernández S, Nagel AG, Serratosa J, Salas J, Viteri C, Llorens J, Baró E.

Epilepsy Behav. 2009 Jun;15(2):154-9. doi: 10.1016/j.yebeh.2008.11.016. Epub 2009 Feb 7.

PMID:
19435575
42.

Postictal psychosis: a retrospective study in patients with refractory temporal lobe epilepsy.

Falip M, Carreño M, Donaire A, Maestro I, Pintor L, Bargalló N, Boget T, Raspall A, Rumià J, Setoaín J.

Seizure. 2009 Mar;18(2):145-9. doi: 10.1016/j.seizure.2008.08.009. Epub 2008 Sep 24.

43.

Diagnostic problems in the initial assessment of epilepsy.

Falip M, Gil-Nagel A, Viteri Torres C, Gómez-Alonso J.

Neurologist. 2007 Nov;13(6 Suppl 1):S2-S10. doi: 10.1097/NRL.0b013e31815bb11b. Review.

PMID:
18090947
44.

Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice.

Carreño M, Maestro I, Molins A, Donaire A, Falip M, Becerra JL, Castillo J.

Seizure. 2007 Dec;16(8):709-12. Epub 2007 Jun 28.

45.

Presurgical evaluation in refractory epilepsy secondary to meningitis or encephalitis: bilateral memory deficits often preclude surgery.

Donaire A, Carreno M, Agudo R, Delgado P, Bargalló N, Setoaín X, Boget T, Raspall T, Falip M, Rumiá J, Pintor L, Maestro I.

Epileptic Disord. 2007 Jun;9(2):127-33.

46.

Parry Romberg syndrome and linear scleroderma in coup de sabre mimicking Rasmussen encephalitis.

Carreño M, Donaire A, Barceló MI, Rumià J, Falip M, Agudo R, Bargalló N, Setoain X, Boget T, Raspall A, Pintor L, Ribalta T.

Neurology. 2007 Apr 17;68(16):1308-10.

PMID:
17438222
47.

Use of levetiracetam in hospitalized patients.

Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.

Epilepsia. 2006 Dec;47(12):2186-8.

48.

Clinical characteristics associated with psychosocial functioning among patients with uncomplicated epilepsy in Spain.

Falip M, Artazcoz L, de la Peña P, Pérez-Sempere A, Codina M; Epilepsy Study Group of the Spanish Society of Neurology.

Seizure. 2007 Apr;16(3):195-203. Epub 2006 Dec 11.

49.

Cortical laminar necrosis related to prolonged focal status epilepticus.

Donaire A, Carreno M, Gómez B, Fossas P, Bargalló N, Agudo R, Falip M, Setoaín X, Boget T, Raspall T, Obach V, Rumiá J.

J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):104-6.

50.

[Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions].

Falip M, Artazcoz L, de la Peña P, Pérez-Sempere A, Martín-Moro M, Codina M; Grupo de Estudio de Epilepsias de la Sociedad Española de Neurología.

Neurologia. 2005 Mar;20(2):71-6. Spanish.

PMID:
15726473

Supplemental Content

Support Center